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Abstract A citrus viroid associated with dwarfing, CVdlIIA, 
has been sequenced and its 294 nucleotide residues can be ar- 
ranged to form the typical rod-like secondary structure of other 
viroids with 71% of nucleotides base-paired. CVdIIIA has great- 
est sequence similarity with apple scar skin viroid (ASSVd; 69%) 
and has the central sequence which is conserved in the ASSVd 
group. CVdIIIA is the smallest member of the ASSVd group but 
contains the terminal conserved region shared by all viroids over 
300 nucleotides. The two ends of CVdIIIA are highly unusual in 
that each end appears to be derived from the conserved central 
core region of a different viroid group. 
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I. Introduction 
Viroids are the smallest plant pathogens known. They consist 
of unencapsidated, circular, single-stranded RNA of 240 375 
bases. Due to extensive intramolecular complementary base 
pairing, viroids form a rod-like structure of short helices and 
small internal oops. However, during thermal denaturation the 
rod-like native structure is disrupted and a metastable structure 
containing at least two large hairpins is formed [1]. Since their 
discovery 23 years ago [2], 21 viroids, excluding variants, have 
been characterised at the molecular level. They can be mechan- 
ically transmitted and multiple infections have been found in 
grape and citrus probably as a result of vegetative propagation 
in these crops. Fifteen viroid-like RNAs have been identified 
in citrus and placed into five groups based on infectivity of 
hosts, hybridization with nucleic acid probes, and estimated 
number of nucleotides [3]. The nucleotide sequence of at least 
one member of each group is known with the exception of 
group III which has at least four uncharacterised members. We 
were interested in characterising the largest member (approxi- 
mately 295 nucleotides) of group I l l  since it was strongly asso- 
*Corresponding author. Fax: (61) (8) 303-8601. 
Abbreviations: AGVd, Australian grapevine viroid; ASBVd, avocado 
sunblotch viroid; ASSVd, apple scar skin viroid; CBLVd, citrus bent 
leaf viroid; CBVd, Coleus blumei viroid; CCCVd, coconut cadang- 
cadang viroid; CCR, central conserved region; CEVd, citrus exocortis 
viroid; CLVd, Columnea latent viroid; CSVd, chrysanthemum stunt 
viroid; CTIVd, coconut inangaja viroid; CVdlIIA, citrus viroid IIIA; 
CVdlV, citrus viroid IV; GYSVdl, grapevine yellow speckle viroid 1; 
GYSVd2, grapevine yellow speckle viroid 2; HLVd, hop latent viroid; 
HSVd, hop stunt viroid; PBCVd, pear blister canker viroid; PLMVd, 
peach latent mosaic viroid; PSTVd, potato spindle tuber viroid; 
TASVd, tomato apical stunt viroid; TCR, terminal conserved region; 
TPMVd, tomato planta macho viroid. 
ciated with dwarfing symptoms in citrus [4-6]. We have cloned 
and sequenced this viroid and in consideration of its prior 
classification [3] will refer to it in this report as citrus viroid 
group III, member A (CVdIIIA). 
2. Materials and methods 
2.1. Propagation of CVdlIIA 
The isolate of CVdlIIA used in this study was originally isolated in 
New South Wales, Australia [6] from Allan Valencia and graft-inocu- 
lated to Etrog citron (Citrus medica). Cuttings from inoculated and 
non-inoculated Etrog citron plants were rooted and maintained in 
glasshouse conditions. 
2.2. CVdlI1A extraction and purification 
For viroid extraction, fresh leaf and stem tissues were frozen in liquid 
nitrogen, ground to powder and homogenised in an extraction medium 
previously described [7]. The viroid contained in the 2 M LiCI soluble 
fraction was concentrated by ethanol precipitation and isolated from 
other nucleic acids by sequential polyacrylamide gel electrophoresis 
(sPAGE) as described [8]. 
2.3. RNA sequencing 
The sequence of 90% of CVdlIIA was obtained by direct RNA 
sequencing of fragments obtained by partial digestion with either 
RNase T~ or RNase U2 under non-denaturing conditions. The frag- 
ments were 5'-end labelled with [y-32p]ATP using polynucleotide ki- 
nase, fractionated on 8% polyacrylamide g ls, eluted and sequenced [9]. 
2.4. Cloning and sequencing of CVdlIIA 
The RNA sequence data was used to design a thirty nucleotide 
primer (P1) (5'-TTTCCCTTTCCCTCTCTGCGTTTT(G/A)TTTTC- 
3') for first strand cDNA synthesis. After confirmation of first strand 
cDNA synthesis, an adjacent twenty nucleotide primer (P2) (5'-CTT- 
ACCTGTCGTCGTCGACG-Y) was used to obtain a full-length PCR 
product of the circular RNA CVdIIIA molecule. Primer 3 (5'-CTTT- 
CCGACTAGCGGAGACTCTCC-3') and Primer 4 (5'-ACTCCGT- 
GTGGTTCCTGTGG-3') flanking the first set of primers were used to 
confirm the sequence bound by the first set. The position of all these 
primers on the CVdlIIA molecule isshown in Fig. 1. Reverse transcrip- 
tion and polymerase chain reaction (RT-PCR) were carried out as 
described [10]. 100 ng of CVdIIIA was mixed with a 100-fold molar 
excess of each primer and heated to 95°C for 2 min and quickly cooled 
on ice. RT-PCR was carried out in 100/11 reactions containing the 
template and primers, 50 mM Tris-HC1 (pH 8.3 at room temperature), 
50 mM KC1, 2.5 units AMV reverse transcriptase (Promega), and 0,5 
unit of Taq DNA polymerase (Promega). The mixture was incubated 
at 42°C for 15 min followed by a 35 cycle PCR program of 1 min at 
94°C, 1 min at 50°C, and 2 rain at 72°C. 
PCR fragments were cloned into a T-tailed Bluescript II SK(+) plas- 
mid (Stratagene, La Jolla, CA) prepared as described [11]. Three inde- 
pendent RT-PCR clones were sequenced in both directions using the 
dideoxynucleotide chain termination method [12] and Sequenase 
Quick-Denature Plasmid Sequencing Kit (US Biochemical, Cleveland, 
OH). 
3. Results and discussion 
Fig. 2A shows the nucleotide sequence of CVdlI IA.  It is a 
circular molecule of 294 nucleotide residues consisting of 72A 
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Fig. 1. The locations of conserved sequences and primers within the 
structure of CVdlIIA. The central conserved region (CCR), the termi- 
nal conserved region (TCR), hairpins I and II (HPI, HPII), and primer 
locations (P1, P2, P3, P4) are identified. 
(24.5%), 74C (25.2%), 86G (29.2%) and 62U (21.1%). The sec- 
ondary structure of CVdlIIA was determined with RNAFOLD 
(PC/GENE, Intelligenetics). The lowest AG structure (-167 
kcal) is unbranched and linear like most other viroids. Overall, 
71% of the bases are paired and consist of 61% GC, 35% AU 
and 4% GU pairs. The CVdlIIA sequence was analysed for the 
presence of open reading frames in both the plus and minus 
strand using AUG and GUG as possible initiation codons. The 
only AUG codon present is in the minus strand (residues 131 
133) and is followed by 15 nucleotides before a stop codon. The 
largest GUG initiated reading frame in the plus strand (residues 
211-48) and in the minus trand (residues 263-148) can theoret- 
ically encode peptides of 44 and 59 amino acid residues, respec- 
tively. Thus, like other viroids, CVdIIIA does not appear to 
encode any proteins. 
Viroid classification based on conserved core sequences [13] 
places CVdlIIA in the ASSVd group. The CCR of CVdlIIA 
contains ixteen core nucleotides in the upper strand and seven- 
teen core nucleotides in the lower strand which are identical 
with the core sequence of the other six members of the ASSVd 
group. CVdlIIA is the smallest group member but contains the 
highest percentage of complimentary base pairs (71% com- 
pared to 69% for AGV) with most being GC pairs (61% com- 
pared to 55% for AGV). In terms of overall sequence homology 
within the ASSVd group, CVdlIIA is most similar to ASSVd 
(69.4% identity) and least similar to GYSVd2 (56.6% identity). 
The lower left terminal region of CVdlIIA contains a twenty- 
eight nucleotide sequence (residues 266-293) with twenty-six 
bases identical in sequence and located in the same relative 
position in ASSVd. 
ASSVd group and PSTVd group viroids have inverted repeat 
sequences that can potentially form the stem structures of vi- 
roid hairpins I and II. Hairpin I includes the upper CCR while 
hairpin II includes the lower CCR in a much larger loop. Diener 
[14] has proposed a model in which formation of hairpin I is 
necessary for processing viroid replication intermediates into 
monomers. Owens et al. [15] and Loss et al. [16] have shown 
that the formation of hairpin II is necessary for infection. 
CVdlIIA has an inverted repeat of 12 bases, with one mis- 
match, that flanks the upper CCR (residues 72-83 and 96-107) 
and can potentially form hairpin I while an inverted repeat of 
11 bases flanks the lower CCR (residues 176-186 and 245-255) 
and can potentially form hairpin II. The relative position of 
these conserved structures in CVdlIIA is shown in Fig. 1. 
Viroids are known to have prominent polypurine and pol- 
ypyrimidine tracts of undetermined biological significance [17]. 
CVdlIIA has a seventeen ucleotide cluster of polypurines 
starting at residue 57 (Fig. 2A). This compares with a pol- 
ypurine cluster of the same length in GYSVdl and one of 
fifteen nucleotides in ASSVd which are located in the same 
relative position. The polypurine symmetry (GGGAAAGGG- 
AAA) in the CVdlIIA cluster is unique. It may have resulted 
from a duplication of the sequence GGGAAA which is part of 
the extended upper CCR sequence in nine of eleven PSTVd 
group members but does not occur in any ASSVd group vi- 
roids. 
To date, the eleven nucleotides (GGTTCCTGTGG) of the 
TCR [18] located in the upper left terminal region of viroids 
(Fig. 1) correlates with viroid size for all ASSVd group and 
PSTVd group viroids. Twelve viroids greater than 300 nucleo- 
tides contain the element and five viroids less than 300 nucleo- 
tides do not contain the sequence. CVdlIIA with 294 nucleo- 
tides contains the TCR and is therefore the first exception to 
the association of TCR with size. CVdlIIA also shares an 
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UA~CCGGUGGAAAC~AACU TPMVd 
UA 2CCGGUGGAAACAACU TASVd 
UA CCGGUGGAAA AACU CEVd 
UA~CCGGUGGAAA~AACU CSVd 
UA~CCGGUGGAAA~A.ACU PSTVd 
UACCCGGUGGAUACAACU CVdIV 
UACCCGGUGGAUACAACU CTIVd 
UACCCGGUGGAUACAACU HLVd 
UACCCGGUGGAUACAACU CCCVd 
CGACCGGUGGCAUCACCU HSVd 
CGACCGGUGGCAUCACCG CLVd 
*t***** 
C. 
CU~CCGCUAGUC~AGCGGACAAC CVdIIIA 
GU~CCGCUAGUCG~GCGGACAAC PBCVd 
UU~CCGCUAGUCqAGCGGACUUC CBLVd 
CC~CCGCUAGUC~AGCGGACUUG GYSVdl 
CC~CCGCUAGUC~AGCGGACUUG GYSVd2 
GU~CCGCUAGUC(~AGCGGACUCG AGVd 
GC(]CCGCUAGUC(IAGCGGACUCC ASSVd 
***************** 
Fig. 2. (A) Nucleotide sequence and proposed secondary structure of CVdlIIA. The upper and lower strands of the CCR and important terminal 
sequences are outlined. (B) Sequence alignment ofthe lower CCR of the PSTVd group showing the seven conserved core nucleotides (*). The left-hand 
terminus of CVdlIIA contains a twelve nucleotide duplication, with one change (U-to-A), of the boxed area. (C) Sequence alignment of the lower 
CCR of the ASSVd group showing the seventeen core nucleotides (*). The right-hand terminus of CVdlIIA contains a ten nucleotide duplication 
of the boxed area. 
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additional three bases (UGU) at the 5' end of the TCR with 
CBLVd, GYSVdl and GYSVd2 which probably indicates that 
its TCR has a common origin with these viroids. 
Keese and Symons [19] have previouly proposed that RNA 
exchanges between viroids occurs in modules or domains which 
contain both the upper and lower strands of RNA. In 
CVdIIIA, the extended upper CCR is most related to ASSVd 
with 81% of the nucleotides being identical in a forty-seven 
nucleotide overlap (residues 60 105). In contrast, he sequence 
of the extended lower CCR is most related to PBCVd with 80% 
of the nucleotides being identical in a thirty-nine nucleotide 
overlap (residues 177-211). Thus, in the case of CVdIIIA, it 
appears that the CCR sequences were exchanged as two indi- 
vidual RNA strands from two different viroids. 
The sequences of the terminal regions of CVdIIIA are highly 
unusual in that they derive from the conserved sequences oftwo 
different CCRs. The left terminus contains twelve nucleotides 
(with one mismatch) from the lower CCR of the PSTVd group 
(Fig. 2B) and the right terminus contains ten nucleotides from 
the lower CCR of the ASSVd group (Fig. 2C). The upper CCR 
which normally base pairs with the lower CCR may, in the case 
of CVdIIIA, form an alternative secondary structure by base 
pairing with the right terminal region. This would not be as 
stable as the native state but may occur during replication of 
the RNA strand as an intermediate conformation or may be 
facilitated by binding of host cell proteins. Studies of other 
viroids have shown the ends do not fold back into a globular 
structure [1]. The biological significance of different conforma- 
tions, if they occur, is unknown but as viroids do not encode 
any translation products, their capability to interact with host 
cell factors for replication and pathogenesis depends on their 
RNA structure and the ability of that structure to undergo 
structural transitions [1]. The single-stranded loop outs of the 
two termini may be prominently positioned for such putative 
interactions. This is the first report of a viroid containing CCR 
nucleotide sequences at both ends. 
The ability of the CCR to form a palindromic structure [14] 
raises the possibility that the right terminal of CVdIIIA may 
base pair with the upper CCR of another CVdIIIA molecule. 
Alternatively, the right terminus of CVdIIIA may base pair 
with the sequence of the upper CCR in a CVdIIIA replication 
intermediate. While palindromic structures formed by inter- 
molecular upper CCR base pairing are believed to be critical 
to processing of viroid replication i termediates into monomers 
[14] the role of such putative additional palindromes in viroid 
replication and processing remains unknown. 
The surprising presence of a second CCR duplication i  the 
left terminus of CVdIIIA, which contains the partial duplica- 
tion of the lower PSTVd group CCR (Fig. 2B), may suggest 
CVdIIIA interacts with the PSTVd group of viroids or alterna- 
tively represents a link in the evolution of these viroids. The 
apparent flexibility observed in the sequence of CVdIIIA ter- 
mini suggests CVdIIIA may be tolerent to other changes intro- 
duced through in vitro mutagenisis. 
CVdIIIA is the second characterised member of the ASSVd 
group infecting citrus and has a history of being strongly asso- 
ciated with a citrus dwarfing phenotype [4-6]. It is the same size 
as an unidentified viroid in the Graft Transmissible Dwarfing 
(GTD) agent 225T [20] used in Israel to deliberately dwarf 
grapefruit trees for greater economy of grove management. All
our glasshouse Etrog citron plants infected with CVdIIIA are 
dwarfed to varying degrees. The use of a descriptive viroid 
name linking CVdIIIA and the citrus dwarfing character would 
be more appropriate, but this will await the confirmation of 
dwarfing effects from current infectivity tests using cloned 
CVdIIIA inocula to rule out the presence of other viroids. 
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